Peter J. Selby

28.2k total citations · 4 hit papers
339 papers, 19.8k citations indexed

About

Peter J. Selby is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Peter J. Selby has authored 339 papers receiving a total of 19.8k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Oncology, 109 papers in Molecular Biology and 64 papers in Immunology. Recurrent topics in Peter J. Selby's work include Virus-based gene therapy research (47 papers), Cancer survivorship and care (44 papers) and Immunotherapy and Immune Responses (44 papers). Peter J. Selby is often cited by papers focused on Virus-based gene therapy research (47 papers), Cancer survivorship and care (44 papers) and Immunotherapy and Immune Responses (44 papers). Peter J. Selby collaborates with scholars based in United Kingdom, United States and Canada. Peter J. Selby's co-authors include Rosamonde E. Banks, Galina Velikova, Julia Brown, Adam B. Smith, Jennifer Southgate, Patricia Harnden, Alan Melcher, Richard G. Vile, Penny Wright and Kevin J. Harrington and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Peter J. Selby

332 papers receiving 19.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

2003 1.3k citations Peter J. Selby et al. profile →
Measuring Quality of Life in Routine Oncology Practice Improves Communication and Patient Well-Being: A Randomized Controlled Trial

2004 1.1k citations Peter J. Selby et al. profile →
The prevalence and outcomes of frailty in older cancer patients: a systematic review

2014 683 citations Peter J. Selby et al. profile →
Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

1991 545 citations Peter J. Selby et al. profile →

Peers

Countries citing papers authored by Peter J. Selby

Since Specialization

Citations

This map shows the geographic impact of Peter J. Selby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Selby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Selby more than expected).

Fields of papers citing papers by Peter J. Selby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Selby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Selby. The network helps show where Peter J. Selby may publish in the future.

Co-authorship network of co-authors of Peter J. Selby

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Selby. A scholar is included among the top collaborators of Peter J. Selby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Selby. Peter J. Selby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ensuring equitable and affordable access to clean water for people living with cancer in a rural and coastal setting 2025 ·Journal of Cancer Policy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ros Kane, Peter J. Selby, Mark Lawler, David Nelson	0
2	Invisible geographies - the rural and coastal blind spot in UK cancer policy: A content analysis 2025 ·Journal of Cancer Policy ·David Nelson, Natália Calanzani, (unknown), Katie Spencer, (unknown), (unknown), Maxime Inghels, (unknown), Ros Kane, (unknown), Eila Watson, (unknown), Rebecca Foster, Lynn Calman, Peter J. Selby, Mark Lawler, Peter Murchie	0
3	Understanding the impact of distance and disadvantage on lung cancer care and outcomes: a study protocol 2024 ·BMC Cancer ·(unknown), Samantha L. Quaife, (unknown), Lucy Mitchinson, Zara Pogson, William Ricketts, Adam Januszewski, (unknown), (unknown), (unknown), Ros Kane, (unknown), Lynn Calman, Peter J. Selby, Michael Peake, David Nelson	2
4	Implementing the European code of cancer practice in rural settings 2024 ·Journal of Cancer Policy ·David Nelson, Peter J. Selby, Ros Kane, (unknown), Amanda Kenny, (unknown), (unknown), Todd Hogue, Kathy Oliver, Mark Gussy, Mark Lawler	5
5	Benefits of Mentoring in Oncology Education for Mentors and Mentees: Pre-Post Interventional Study of the British Oncology Network for Undergraduate Societies' National Oncology Mentorship Scheme 2023 ·JMIR Medical Education ·(unknown), (unknown), (unknown), (unknown), (unknown), Peter J. Selby, Christopher P. Millward	1
6	Developing a ‘Living with Cancer’ programme in a rural and coastal setting: Experiences of collaborative and innovative co-production across an Integrated Health System 2023 ·Journal of Cancer Policy ·(unknown), (unknown), David Nelson, Peter J. Selby, (unknown), Mark Gussy, Ros Kane	3
7	Development and validation of multivariable machine learning algorithms to predict risk of cancer in symptomatic patients referred urgently from primary care: a diagnostic accuracy study 2022 ·BMJ Open ·Richard S. Savage, (unknown), Richard D Neal, (unknown), C. Johnston, (unknown), (unknown), (unknown), Peter J. Selby, Nisha Sharma, Bethany Shinkins, (unknown), (unknown), (unknown), Geoff Hall	4
8	Implementing the European Code of Cancer Practice to Improve Europe’s Cancer Outcomes 2021 ·Mark Lawler, Kathy Oliver, (unknown), (unknown), (unknown), Matti Aapro, (unknown), (unknown), Richard Price, Peter J. Selby	0
9	Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment 2019 ·Cancer Immunology Research ·Laura Evgin, Amanda L. Huff, Timothy Kottke, Jill Thompson, Amy M. Molan, Christopher B. Driscoll, Matthew Schuelke, Kevin G. Shim, Phonphimon Wongthida, Elizabeth J. Ilett, (unknown), Reuben S. Harris, Matt Coffey, José S. Pulido, Hardev Pandha, Peter J. Selby, Kevin J. Harrington, Alan Melcher, Richard G. Vile	13
10	Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study 2018 ·Diagnostics ·Tze Min Wah, Steven Sourbron, Daniel J. Wilson, Derek Magee, Walter M. Gregory, Peter J. Selby, David L. Buckley	6
11	Blogging to Quit Smoking: Sharing Stories from Women of Childbearing Years in Ontario 2016 ·SHILAP Revista de lepidopterología ·Nadia Minian, Aliya Noormohamed, Rosa Dragonetti, Julie E. Maher, (unknown), Peter J. Selby	0
12	Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection 2013 ·Clinical Cancer Research ·Fiona Collinson, (unknown), Rachel A. Craven, David A. Cairns, Alexandre Zougman, (unknown), (unknown), Michael Messenger, Sharon Jackson, Douglas Thompson, (unknown), Jonathan A. Ledermann, Geoffrey Hall, Gordon C. Jayson, Peter J. Selby, Rosamonde E. Banks	58
13	Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice 2010 ·Journal of Clinical Investigation ·Timothy Kottke, Geoff Hall, José S. Pulido, Rosa María Díaz, Jill Thompson, Heung Chong, Peter J. Selby, Matt Coffey, Hardev Pandha, John Chester, Alan Melcher, Kevin J. Harrington, Richard G. Vile	68
14	Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma 2009 ·Clinical Cancer Research ·(unknown), Rachel A. Craven, D. Cohen, Claire Taylor, Christopher Booth, Patricia Harnden, David A. Cairns, Dewi Astuti, Walter M. Gregory, Eamonn R. Maher, Margaret A. Knowles, Adrian Joyce, Peter J. Selby, Rosamonde E. Banks	137
15	Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival 2008 ·Clinical Cancer Research ·Naveen Vasudev, Janet E. Brown, Sarah Brown, Rumana Rafiq, Ruth M. Morgan, (unknown), (unknown), Patricia Harnden, Mark A. Rogers, Kim Cocks, (unknown), Alan Paul, Ian Eardley, Peter J. Selby, Rosamonde E. Banks	31
16	Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma 2008 ·Gene Therapy ·Fiona Errington‐Mais, Charles L. White, Katie Twigger, Ailsa Rose, Karen J. Scott, Lynette P. Steele, Elizabeth J. Ilett, Robin Prestwich, (unknown), Matthew Coffey, Peter J. Selby, Richard G. Vile, Kevin J. Harrington, Alan Melcher	86
17	Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges 2008 ·Molecular BioSystems ·Niroshini Nirmalan, Patricia Harnden, Peter J. Selby, Rosamonde E. Banks	67
18	Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity 2008 ·The Journal of Immunology ·Fiona Errington‐Mais, Lynette P. Steele, Robin Prestwich, Kevin J. Harrington, Hardev Pandha, Laura Vidal, Johann S. de Bono, Peter J. Selby, Matt Coffey, Richard G. Vile, Alan Melcher	150
19	Genetic and Epigenetic Analysis of von Hippel-Lindau ( VHL ) Gene Alterations and Relationship with Clinical Variables in Sporadic Renal Cancer 2006 ·Cancer Research ·Rosamonde E. Banks, Prasanna Tirukonda, Claire Taylor, Nick Hornigold, Dewi Astuti, D. Cohen, Eamonn R. Maher, Anthea J. Stanley, Patricia Harnden, Adrian Joyce, Margaret A. Knowles, Peter J. Selby	214
20	Intrinsic chemotherapy resistance to the tubulin‐binding antimitotic agents in renal cell carcinoma 2005 ·International Journal of Cancer ·Roisean E. Ferguson, Sharon M. Jackson, Anthea J. Stanley, Adrian Joyce, Patricia Harnden, Ewan E. Morrison, Poulam M. Patel, Roger M. Phillips, Peter J. Selby, Rosamonde E. Banks	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact